Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L GELLER

Showing results (481-490 of 489) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 489 results.
The New England Journal of Medicine|April 9, 2015
Surgical ablation of atrial fibrillation during mitral-valve surgeryA Marc Gillinov, Annetine C Gelijns, Michael K Parides, et al.
Blood Advances|March 18, 2025
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704Mohamed L Sorror, Wael Saber, Brent R Logan, et al.
American Journal of Obstetrics & Gynecology MFM|October 19, 2024
Antihypertensive therapy and unplanned maternal postpartum healthcare utilization in patients with mild chronic hypertensionAnna Palatnik, Justin Leach, Lorie Harper, et al.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
The Lancet. Haematology|March 3, 2019
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)Javier Bolaños-Meade, Ran Reshef, Raphael Fraser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>Mark J Levis, Mehdi Hamadani, Brent Logan, et al.
The New England Journal of Medicine|April 1, 2022
Treatment for Mild Chronic Hypertension during PregnancyAlan T Tita, Jeff M Szychowski, Kim Boggess, et al.
Obstetrics and Gynecology|July 1, 2024
Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic HypertensionAyodeji A Sanusi, Justin Leach, Kim Boggess, et al.
Anatomical Sciences Education|April 4, 2023
Personal autonomy and self-determination are crucial for professionalism in healthcareJason M Organ, Heather F Smith, Paul A Trainor, et al.
Pageof 49

Showing results (481-490 of 489) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 489 results.
The New England Journal of Medicine|April 9, 2015
Surgical ablation of atrial fibrillation during mitral-valve surgeryA Marc Gillinov, Annetine C Gelijns, Michael K Parides, et al.
Blood Advances|March 18, 2025
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704Mohamed L Sorror, Wael Saber, Brent R Logan, et al.
American Journal of Obstetrics & Gynecology MFM|October 19, 2024
Antihypertensive therapy and unplanned maternal postpartum healthcare utilization in patients with mild chronic hypertensionAnna Palatnik, Justin Leach, Lorie Harper, et al.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
The Lancet. Haematology|March 3, 2019
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)Javier Bolaños-Meade, Ran Reshef, Raphael Fraser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>Mark J Levis, Mehdi Hamadani, Brent Logan, et al.
The New England Journal of Medicine|April 1, 2022
Treatment for Mild Chronic Hypertension during PregnancyAlan T Tita, Jeff M Szychowski, Kim Boggess, et al.
Obstetrics and Gynecology|July 1, 2024
Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic HypertensionAyodeji A Sanusi, Justin Leach, Kim Boggess, et al.
Anatomical Sciences Education|April 4, 2023
Personal autonomy and self-determination are crucial for professionalism in healthcareJason M Organ, Heather F Smith, Paul A Trainor, et al.
Pageof 49